GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) plans to spin out its corporate VC arm SR One, according to a source familiar with the matter.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,